Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/XBRA stock hub

CSE/XBRA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/XBRAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

420.7K

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/XBRA

In the news

Latest news · CSE/XBRA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROICn/a

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/XBRA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

Groups with data

Currency

CAD

Showing 81 of 81 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA98402E2069
Last refreshed	2026-05-10
Market cap	CAD 420,724
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
Sic	2833
Symbol	cse/XBRA
Website	https://xebrabrands.com

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-90.02%
Cagr3y	-75.12%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
WACC	-7.35

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-90%
200-day SMA	0.04
3Y total return	-98.46%
50-day SMA	0.02
50-day SMA vs 200-day SMA	50under200
All Time High	4.15
All Time High Change	-99.88%
All Time High Date	2021-12-02
All Time Low	0.01
All Time Low Change	0%
All Time Low Date	2025-08-19
ATR	0
Beta	-2.11
Beta1y	-0.81
Beta2y	-0.67
Ch YTD	-80
High	0.01
High52	0.09
High52 Date	2025-03-28
High52ch	-94.44%
Low	0.01
Low52	0.01
Low52 Date	2025-09-04
Low52ch	0%
Ma50ch	-77.88%
Price vs 200-day SMA	-88.15%
RSI	36.48
RSI Monthly	43.88
RSI Weekly	34
Sharpe ratio	0.12x
Sortino ratio	0.22
Tr YTD	-80
Tr1m	-75%
Tr1w	-50%
Tr3m	-85.71%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares Insiders	20.34%
Shares Out	84,144,855

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	183,598.5x
Ch1m	-75
Ch1w	-50
Ch1y	-90
Ch3m	-85.71
Ch3y	-98.46
Ch6m	-88.89
Change	0%
Change From Open	0
Close	0.01
Days Gap	0
Dollar Volume	16
F Score	0
Founded	2,019
Is Primary Listing	1
Last Split Date	2023-02-28
Last Split Type	Reverse
Ma150	0.04
Ma150ch	-87.83%
Ma20	0.01
Ma20ch	-57.26%
Open	0.01
Price Date	2025-09-03
Relative Volume	0.02x
Tr6m	-88.89%
Volume	3,200

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/XBRA pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/XBRA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/XBRA?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+20.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

CSE/XBRA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.5

Neutral momentum band

Price vs 200-day MA

-88.2%

50/200-day relationship not available

Beta (5Y)

-2.11

Less volatile than the market

Sharpe ratio

0.12

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/XBRA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/XBRA stock rating?

cse/XBRA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/XBRA analysis?

The full report lives at /stocks/cse/XBRA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/XBRA?

The latest report frames cse/XBRA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/XBRA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.